1. Tomono T, Hirai Y, Okada H, Miyagawa Y, Adachi K, Sakamoto S, Kawano Y, Chono H, Mineno J, Ishii A, Shimada T, Onodera M, Tamaoka A, Okada T. Highly Efficient Ultracentrifugation-free Chromatographic Purification of Recombinant AAV Serotype 9. Mol Ther Methods Clin Dev. 2018, 11, 180-90, doi: 10.1016/j.omtm.2018.10.015.
2. 青木吉嗣,岡田尚巳,武田伸一. 筋ジストロフィーの遺伝子治療, PrecisionMedicine. 2018, 北隆館, 東京, 2018年12月
3. 青木吉嗣、滝澤歩武、武田伸一. Duchenne型筋ジストロフィーのエクソン・スキップ治療法.2018,神経内科,科学評論社, 525-530, 2018年11月
4. Miyatake S, Mizobe Y, Tsoumpra MK, Lim KRQ, Hara Y, Shabanpoor F, Yokota T, Takeda S, Aoki Y. Scavenger Receptor Class A1 Mediates Uptake of Morpholino Antisense Oligonucleotide into Dystrophic Skeletal Muscle. Molecular therapy. Nucleic acids. 2019年1月
5. Kuraoka M, Nitahara-Kasahara Y, Tachimori H, Kato N, Shibasaki H, Shin A, Aoki Y, Kimura E, Takeda S.Accelerometric outcomes of motor function related to clinical evaluations and muscle involvement in dystrophic dogs. PloS one, 2018年12月
6. Shimizu-Motohashi Y, Komaki H, Motohashi N, Takeda S, Yokota T, Aoki Y. Restoring Dystrophin Expression in Duchenne Muscular Dystrophy: Current Status of Therapeutic Approaches. Journal of personalized medicine, 2019年1月
7. Takizawa H, Hara Y, Mizobe Y, Ohno T, Suzuki S, Inoue K, Takeshita E, Shimizu-Motohashi Y, Ishiyama A, Hoshino M, Komaki H, Takeda S, Aoki Y. Modelling Duchenne muscular dystrophy in MYOD1-converted urine-derived cells treated with 3-deazaneplanocin A hydrochloride. Scientific reports, 2019年3月